Toggle Offcanvas
...
 
Dapagliflozin Tenders

Dapagliflozin Tenders

View Dapagliflozin tenders, RFPs and contracts. Bid on readily available Dapagliflozin tenders with the best and most comprehensive tendering platform, since 2002.
Dapagliflozin is a medication used to lower blood sugar levels in people with type 2 diabetes. It works by helping the kidneys remove excess glucose from the body through urine, making it easier to control blood sugar levels.

Bidding for Dapagliflozin tenders is extremely lucrative for companies of all sizes. Tendering authorities and private companies release thousands of contracts worth millions for procurement of Dapagliflozin.

Global Tenders stands out as the largest platform dedicated to pharmaceutical tenders and government contracts. Boasting over 20 years of experience in the tender business, GlobalTenders offers the most extensive and reliable Tenders/RFPs/Contracts Database available. The platform aggregates contracts from both public and private sources, connecting with a vast network of over half a million buyers. Employing advanced artificial intelligence, our meticulous process involves gathering information from over a hundred thousand sources. The data is then intelligently categorized into thousands of subcategories for easy filtering and presenting it in a user-friendly format for quick comprehension.

In addition to tender information, we offer in-depth Dapagliflozin market analysis, bid consultancy services, and insights into top bidders and winners.

Sign up now to get instant access to unlimited Dapagliflozin tenders, advanced search filters, market analysis, industry trends, tender training and 24/7 customer support.

36 Live Notices for Dapagliflozin Tenders

Showing 1 to 20

Open House Original Discount Contracts 2025-20 - Metformin/Dapagliflozin (Combination Of Active Ingredients)
country Germany
posting date20 May 2025
deadline31 Jul 2027
Open House Original Discount Contracts 2025-20 - Metformin/Dapagliflozin (Combination Of Active Ingredients)
country Germany
posting date20 May 2025
deadline31 Jul 2027
The Object Of Purchase Is Other/Other Medicines In Accordance With Paragraph 1.2 (Price Table - Annex N1).
country Georgia
posting date17 May 2025
deadline30 May 2025
Pharmaceutical Discount Agreements From February 1, 2025 For Various Active Ingredients Within The Framework Of An Open-House Procedure
country Germany
posting date12 Dec 2024
deadline02 Dec 2026
Medicines Containing The Active Ingredient Dapagliflozin (Atc: A10Bk01)
country Germany
posting date27 Aug 2024
deadline31 Jul 2026
Conclusion Of A Non-Exclusive Discount Agreement Pursuant To Section 130A Paragraph 8 Sgb V For The Active Ingredient Dapagliflozin + Metformin, Atc A10Bd15 (Obo) For The Period 01.10.2024 - 30.09.2026
country Germany
posting date19 Aug 2024
deadline05 Aug 2026
Conclusion Of A Non-Exclusive Discount Agreement Pursuant To Section 130A Paragraph 8 Sgb V For The Active Ingredient Dapagliflozin, Atc A10Bk01 (Obo) For The Period 01.10.2024 - 30.09.2026
country Germany
posting date19 Aug 2024
deadline05 Aug 2026
Conclusion Of A Non-Exclusive Discount Agreement Pursuant To Section 130A Paragraph 8 Sgb V For The Active Ingredient Dapagliflozin, Atc A10Bk01 (Obo) For The Period 01.10.2024 - 30.09.2026
country Germany
posting date17 Aug 2024
deadline05 Aug 2026
Open House Original Discount Agreements 2023-20 - Metformin/Dapagliflozin (Drug Combination)
country Germany
posting date17 Jun 2023
deadline31 Jul 2025
Open House Original Discount Agreements 2023-20 - Metformin/Dapagliflozin (Drug Combination)
country Germany
posting date17 Jun 2023
deadline31 Jul 2025
Open House Original Discount Agreements 2023-20 - Metformin/Dapagliflozin (Drug Combination)
country Germany
posting date15 Jun 2023
deadline31 Jul 2025
Dapa10 Mg. Diampa 10 Mg
country Uzbekistan
posting date26 May 2025
deadline25 May 2026
Estimation: Providing Chemicals, Standard Substances, Supplies, Tools On The Topic: Researching Two -Layer Metformin Hydrochloride Metin -Layer, Prolonged Release And Dapagliflozin Instantaneous Release Equivalent Dissolved In Diabetes Treatment Tip 2
country Vietnam
posting date24 May 2025
deadline23 May 2026
Alphacer 1000 Mg
country Uzbekistan
posting date10 May 2025
deadline10 May 2026
Dapa10 Mg
country Uzbekistan
posting date10 May 2025
deadline10 May 2026
Children Of The Tum Of The Help 21.04.2025
country Uzbekistan
posting date21 Apr 2025
deadline21 Apr 2026
Children Of The Tum Of The Help 21.04.2025
country Uzbekistan
posting date21 Apr 2025
deadline21 Apr 2026
Dapagliflozin 10Mg Tab
country India
posting date28 May 2025
deadline10 Jun 2025
Dapagliflozin 10 Mg Oral Tablet
country India
posting date24 May 2025
deadline18 Jun 2025
1.Linagliptin 5 Mg Oral Tablet.2.Dapagliflozin 10 Mg Oral Tablet
country India
posting date24 May 2025
deadline18 Jun 2025

Share Share this page